Rituxan approved for pediatric patients with rare vasculitis diseases
(HealthDay)—Rituxan (rituximab) injection was granted the first approval for a drug to treat granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) in combination with glucocorticoids in children 2 years ...
Oct 1, 2019
0
3